PremiumADMA

We identified an unusual insider trade at an interesting timing in a biotechnology company

A senior executive at a biotechnology company made a significant stock purchase, concurrently with a buyback program and the development of a new drug.

By the SpyStocks desk · 5mo ago · 3 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Hot stock alerts, straight to Telegram

Real-time buys, sweeps, and trading halts from the desk. Free to join.

Join the channel

We identified an unusual insider trade at an interesting timing in a biotechnology company

The rest is for members

Hot stock alerts, straight to Telegram

Related Stories

Major move in Somnigroup International: CEO buys almost $1.9 million, day after major deal completion

Major move in Somnigroup International: CEO buys almost $1.9 million, day after major deal completion

Will Pfizer do a Moderna for investors?

Will Pfizer do a Moderna for investors?

Intriguing activity in Madison Air

Intriguing activity in Madison Air